Hosted in Miami Beach, the Barclays Global Healthcare Conference brings together a truly global mix of around 110 biopharma companies and 25 large pharmas, alongside leaders across healthcare services, IT and MedTech. This year’s agenda included a speech on the evolving regulatory environment and its implications for innovation and patient outcomes, deep dive panels on GLP 1s, genomics and immunology, and an inaugural private company track with Westlake Bio Partners and Novo Holdings spotlighting likely IPO candidates. Building on that momentum, Barclays experts across Investment Banking and Research joined Biotech TV to share the forces they see shaping biotech in 2026.
Read the full article: Key Takeaways from Barclays’ 28th Global Healthcare Conference //
Source: https://www.ib.barclays/news-and-events/biotechtv-barclays-global-healthcare-conference.html